<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK326661" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK326661/" /><meta name="ncbi_pagename" content="CLCN2-Related Leukoencephalopathy - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>CLCN2-Related Leukoencephalopathy - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="CLCN2-Related Leukoencephalopathy" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/11/05" /><meta name="citation_author" content="Marjo S van der Knaap" /><meta name="citation_author" content="Christel Depienne" /><meta name="citation_author" content="Frederic Sedel" /><meta name="citation_author" content="Truus EM Abbink" /><meta name="citation_pmid" content="26539602" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK326661/" /><meta name="citation_keywords" content="Chloride channel protein 2" /><meta name="citation_keywords" content="CLCN2" /><meta name="citation_keywords" content="CLCN2-Related Leukoencephalopathy" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="CLCN2-Related Leukoencephalopathy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Marjo S van der Knaap" /><meta name="DC.Contributor" content="Christel Depienne" /><meta name="DC.Contributor" content="Frederic Sedel" /><meta name="DC.Contributor" content="Truus EM Abbink" /><meta name="DC.Date" content="2015/11/05" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK326661/" /><meta name="description" content="CLCN2-related leukoencephalopathy (CC2L) is characterized by nonspecific neurologic findings, mild visual impairment from chorioretinopathy or optic atrophy, male infertility, and characteristic findings on brain MRI. Neurologic findings include mild ataxia (action tremor and gait instability following initially normal motor development; occasionally mild spasticity), learning disabilities in some (ranging from mild to severe cognitive impairment), and headaches in some (usually intermittent, severe, and diffuse). Affected individuals remain ambulatory and do not require support for walking, and none has become blind. To date CC2L has been reported or identified in 16 individuals from 15 families. It is not yet known if the findings occurring in single individuals (i.e., vertigo, tinnitus, and progressive hearing loss; psychiatric symptoms; and paroxysmal kinesigenic dyskinesia) are part of the phenotypic spectrum or unrelated findings." /><meta name="og:title" content="CLCN2-Related Leukoencephalopathy" /><meta name="og:type" content="book" /><meta name="og:description" content="CLCN2-related leukoencephalopathy (CC2L) is characterized by nonspecific neurologic findings, mild visual impairment from chorioretinopathy or optic atrophy, male infertility, and characteristic findings on brain MRI. Neurologic findings include mild ataxia (action tremor and gait instability following initially normal motor development; occasionally mild spasticity), learning disabilities in some (ranging from mild to severe cognitive impairment), and headaches in some (usually intermittent, severe, and diffuse). Affected individuals remain ambulatory and do not require support for walking, and none has become blind. To date CC2L has been reported or identified in 16 individuals from 15 families. It is not yet known if the findings occurring in single individuals (i.e., vertigo, tinnitus, and progressive hearing loss; psychiatric symptoms; and paroxysmal kinesigenic dyskinesia) are part of the phenotypic spectrum or unrelated findings." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK326661/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cc2-leuk/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK326661/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D2FC2E03F856100000000084D02CD.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK326661_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK326661_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cd-chst3/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/clcn7/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK326661_"><span class="title" itemprop="name"><i>CLCN2</i>-Related Leukoencephalopathy</span></h1><p class="contrib-group"><span itemprop="author">Marjo S van der Knaap</span>, MD, PhD, <span itemprop="author">Christel Depienne</span>, PhD, <span itemprop="author">Frederic Sedel</span>, MD, and <span itemprop="author">Truus EM Abbink</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK326661_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK326661_ai__"><div class="contrib half_rhythm"><span itemprop="author">Marjo S van der Knaap</span>, MD, PhD<div class="affiliation small">Department of Child Neurology and Neuroscience Campus Amsterdam<br />VU University Medical Center<br />Amsterdam, Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuv@paankrednav.sm" class="oemail">ln.cmuv@paankrednav.sm</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Christel Depienne</span>, PhD<div class="affiliation small">INSERM, U1127&#x02013;ICM<br />H&#x000f4;pital Piti&#x000e9;-Salp&#x000ea;tri&#x000e8;re<br />Paris, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.cmpu@enneiped.letsirhc" class="oemail">rf.cmpu@enneiped.letsirhc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Frederic Sedel</span>, MD<div class="affiliation small">MedDay Pharmaceuticals<br />ICM-Brain and Spine Institute-IPEPs<br />Groupe Hospitalier Piti&#x000e9;-Salp&#x000ea;tri&#x000e8;re<br />Paris, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.amrahp-yaddem@ledes.cirederf" class="oemail">moc.amrahp-yaddem@ledes.cirederf</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Truus EM Abbink</span>, PhD<div class="affiliation small">Department of Child Neurology and Neuroscience Campus Amsterdam<br />VU University Medical Center<br />Amsterdam, Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuv@knibba.g" class="oemail">ln.cmuv@knibba.g</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">November 5, 2015</span>.</p><p><em>Estimated reading time: 14 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cc2-leuk.Summary" itemprop="description"><h2 id="_cc2-leuk_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>CLCN2</i>-related leukoencephalopathy (CC2L) is characterized by nonspecific neurologic findings, mild visual impairment from chorioretinopathy or optic atrophy, male infertility, and characteristic findings on brain MRI. Neurologic findings include mild ataxia (action tremor and gait instability following initially normal motor development; occasionally mild spasticity), learning disabilities in some (ranging from mild to severe cognitive impairment), and headaches in some (usually intermittent, severe, and diffuse). Affected individuals remain ambulatory and do not require support for walking, and none has become blind. To date CC2L has been reported or identified in 16 individuals from 15 families. It is not yet known if the findings occurring in single individuals (i.e., vertigo, tinnitus, and progressive hearing loss; psychiatric symptoms; and paroxysmal kinesigenic dyskinesia) are part of the phenotypic spectrum or unrelated findings.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of CC2L is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CLCN2</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Supportive care including physical therapy and rehabilitation to improve motor function, special education as needed, treatment of headache, guidance for visual impairment.</p><p><i>Surveillance:</i> Annual: neurologic examination, ophthalmologic examination, and audiologic assessment</p><p><i>Evaluation of relatives at risk:</i> Presymptomatic diagnosis and treatment is warranted in older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> to identify those who would benefit from early diagnosis and routine surveillance for motor, cognitive, vision, and hearing impairment.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>CC2L is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible when the <i>CLCN2</i> pathogenic variants in the family are known.</p></div></div><div id="cc2-leuk.Diagnosis"><h2 id="_cc2-leuk_Diagnosis_">Diagnosis</h2><div id="cc2-leuk.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>CLCN2</i>-related leukoencephalopathy (CC2L) <b>should be suspected</b> in individuals with certain nonspecific neurologic findings, decreased visual acuity, and characteristic abnormalities on brain MRI [<a class="bk_pop" href="#cc2-leuk.REF.depienne.2013.659">Depienne et al 2013</a>, <a class="bk_pop" href="#cc2-leuk.REF.di_bella.2014.1217">Di Bella et al 2014</a>, <a class="bk_pop" href="#cc2-leuk.REF.hanagasi.2015.544">Hanagasi et al 2015</a>].</p><div id="cc2-leuk.Neurologic"><h4>Neurologic</h4><ul><li class="half_rhythm"><div>Mild ataxia</div></li><li class="half_rhythm"><div>Learning disabilities</div></li><li class="half_rhythm"><div>Headache</div></li></ul></div><div id="cc2-leuk.Visual"><h4>Visual</h4><ul><li class="half_rhythm"><div>Decreased vision caused by chorioretinopathy or optic atrophy</div></li></ul></div><div id="cc2-leuk.Brain_MRI"><h4>Brain MRI</h4><p><b>Major criteria.</b> Abnormally low signal on T<sub>1</sub>-weighted images and abnormally high signal on T<sub>2</sub>-weighted images (<a class="figpopup" href="/books/NBK326661/figure/cc2-leuk.F1/?report=objectonly" target="object" rid-figpopup="figcc2leukF1" rid-ob="figobcc2leukF1">Figure 1</a>) in the:</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figcc2leukF1" co-legend-rid="figlgndcc2leukF1"><a href="/books/NBK326661/figure/cc2-leuk.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figcc2leukF1" rid-ob="figobcc2leukF1"><img class="small-thumb" src="/books/NBK326661/bin/cc2-leuk-Image001.gif" src-large="/books/NBK326661/bin/cc2-leuk-Image001.jpg" alt="Figure 1. . MRI of an individual age 50 years with CC2L." /></a><div class="icnblk_cntnt" id="figlgndcc2leukF1"><h4 id="cc2-leuk.F1"><a href="/books/NBK326661/figure/cc2-leuk.F1/?report=objectonly" target="object" rid-ob="figobcc2leukF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">MRI of an individual age 50 years with CC2L. Note the T<sub>2</sub>-weighted signal abnormalities (a-d) in the middle cerebellar peduncles (blue arrow in a), cerebral peduncles (green arrow in b), and posterior limb of the internal capsule (red arrow in d). All <a href="/books/NBK326661/figure/cc2-leuk.F1/?report=objectonly" target="object" rid-ob="figobcc2leukF1">(more...)</a></p></div></div><ul><li class="half_rhythm"><div>Posterior limbs of the internal capsules</div></li><li class="half_rhythm"><div>Midbrain cerebral peduncles</div></li><li class="half_rhythm"><div>Middle cerebellar peduncles</div></li></ul><p><b>Supportive criteria</b></p><ul><li class="half_rhythm"><div class="half_rhythm">Abnormally low signal on T<sub>1</sub>-weighted images and abnormally high signal on T<sub>2</sub>-weighted images in the:</div><ul><li class="half_rhythm"><div>Pyramidal tracts in the pons</div></li><li class="half_rhythm"><div>Central tegmental tracts in medulla, pons and midbrain</div></li><li class="half_rhythm"><div>Superior cerebellar peduncles</div></li><li class="half_rhythm"><div>Decussation of the superior cerebellar peduncles in the midbrain</div></li><li class="half_rhythm"><div>Cerebellar white matter</div></li><li class="half_rhythm"><div>Corpus callosum</div></li><li class="half_rhythm"><div>Cerebral white matter, either with a signal behavior suggestive of hypomyelination<sup>*</sup> or nonspecific, mild inhomogeneous signal abnormalities.</div></li></ul><div class="half_rhythm">* Mild T<sub>2</sub>-weighted hyperintensity of the white matter and mild T<sub>1</sub>-weighted hypointensity, isointensity, or hyperintensity relative to gray matter [<a class="bk_pop" href="#cc2-leuk.REF.schiffmann.2009.750">Schiffmann &#x00026; van der Knaap 2009</a>]</div></li><li class="half_rhythm"><div class="half_rhythm">Diffusion restriction (assessed by apparent diffusion coefficient values [<a class="bk_pop" href="#cc2-leuk.REF.depienne.2013.659">Depienne et al 2013</a>]) in part or all of the structures mentioned under major and supportive criteria</div><div class="half_rhythm">Note: More recently an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual had no diffusion restriction [<a class="bk_pop" href="#cc2-leuk.REF.di_bella.2014.1217">Di Bella et al 2014</a>].</div></li></ul></div><div id="cc2-leuk.Other"><h4>Other</h4><ul><li class="half_rhythm"><div><b>Male infertility</b> caused by oligospermia/azoospermia</div></li></ul></div></div><div id="cc2-leuk.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of CC2L <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CLCN2</i> (see <a class="figpopup" href="/books/NBK326661/table/cc2-leuk.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="figcc2leukTmoleculargenetictestinguse" rid-ob="figobcc2leukTmoleculargenetictestinguse">Table 1</a>).</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>CLCN2</i> is performed first followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>CLCN2</i> and other genes of interest (see <a href="#cc2-leuk.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) fails to confirm a diagnosis in an individual with features of chloride channel-2 related leukoencephalopathy.</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="cc2-leuk.T.molecular_genetic_testing_use" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Chloride Channel-2 Related Leukoencephalopathy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK326661/table/cc2-leuk.T.molecular_genetic_testing_use/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cc2-leuk.T.molecular_genetic_testing_use_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>CLCN2</i></td><td headers="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">All <i>CLCN2</i> pathogenic variants reported to date</td></tr><tr><td headers="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4</sup></td><td headers="hd_h_cc2-leuk.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>5</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cc2-leuk.TF.1.1"><p class="no_margin">See <a href="/books/NBK326661/#cc2-leuk.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="cc2-leuk.TF.1.2"><p class="no_margin">See <a href="#cc2-leuk.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="cc2-leuk.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="cc2-leuk.TF.1.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>5. </dt><dd><div id="cc2-leuk.TF.1.5"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div></div><div id="cc2-leuk.Clinical_Characteristics"><h2 id="_cc2-leuk_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cc2-leuk.Clinical_Description"><h3>Clinical Description</h3><p>Since its discovery in 2013, <i>CLCN2</i>-related leukoencephalopathy (CC2L) has been reported in eight individuals [<a class="bk_pop" href="#cc2-leuk.REF.depienne.2013.659">Depienne et al 2013</a>, <a class="bk_pop" href="#cc2-leuk.REF.di_bella.2014.1217">Di Bella et al 2014</a>, <a class="bk_pop" href="#cc2-leuk.REF.hanagasi.2015.544">Hanagasi et al 2015</a>] and diagnosed in eight additional individuals from seven families [Author, personal observation]. Consequently, the phenotypic spectrum may only be partially known and statements about relative frequency of features are of limited value.</p><p>The phenotypic spectrum of CC2L ranges from childhood onset with mild ataxia, learning disabilities, and headaches to adult onset with mild ataxia and decreased vision. Infertility has been observed in two adult males [<a class="bk_pop" href="#cc2-leuk.REF.di_bella.2014.1217">Di Bella et al 2014</a>; Author, personal observation]. To date, single individuals with vertigo, tinnitus, and progressive hearing loss [<a class="bk_pop" href="#cc2-leuk.REF.depienne.2013.659">Depienne et al 2013</a>]; psychiatric symptoms [<a class="bk_pop" href="#cc2-leuk.REF.depienne.2013.659">Depienne et al 2013</a>]; and paroxysmal kinesigenic dyskinesia [<a class="bk_pop" href="#cc2-leuk.REF.hanagasi.2015.544">Hanagasi et al 2015</a>] have been reported. Thus, it is not yet clear if these findings are part of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> or unrelated findings.</p><p>The disease course has been reported as stable to slowly progressive; considering that adults were previously normal, extremely slow progression is most likely. All individuals reported to date have remained ambulatory. The oldest known individual with CC2L is age 65 years. No disease-related deaths have been reported to date.</p><p><b>Motor skills.</b> Initial motor development is normal. At presentation, most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals display signs of mild cerebellar ataxia with action tremor and gait instability; some also show mild signs of spasticity.</p><p>Affected individuals remain ambulatory and do not require support for walking.</p><p><b>Cognitive skills.</b> Some have mild learning problems from early on, but most have normal intellect. One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual had severe cognitive impairment and psychosis.</p><p><b>Headache.</b> Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals complain of intermittent severe diffuse headaches [Author, personal observation].</p><p><b>Eyes.</b> Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a retinopathy or optic atrophy leading to mild visual impairment. Some affected individuals have visual field defects at formal testing, indicating subclinical retinopathy. None has become blind.</p><p><b>Male infertility.</b> One male with azoospermia (but no neurologic dysfunction) was found to have CC2L during a work-up for infertility [<a class="bk_pop" href="#cc2-leuk.REF.di_bella.2014.1217">Di Bella et al 2014</a>]. One male with a history of infertility was diagnosed with CC2L when he was investigated for severe headaches [Author, personal observation].</p><p><b>Routine laboratory tests,</b> including CSF analysis, are normal.</p></div><div id="cc2-leuk.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Individuals with two <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> alleles and individuals with two <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> pathogenic variants have been reported with onset in either childhood or adulthood without evidence of any <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a>, although it should be noted that to date the number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported and known to the authors is small.</p></div><div id="cc2-leuk.Prevalence"><h3>Prevalence</h3><p>The prevalence of CC2L is unknown. The small number of known <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals suggests that the disease is exceedingly rare. Numerous individuals with CC2L, however, may also remain undiagnosed because they remain asymptomatic at an advanced age, lack a specific clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, or have findings (e.g., headaches or infertility due to azoospermia or oligozoospermia) that do not prompt evaluation by brain MRI.</p></div></div><div id="cc2-leuk.Genetically_Related_Allelic_Dis"><h2 id="_cc2-leuk_Genetically_Related_Allelic_Dis_">Genetically Related (Allelic) Disorders</h2><p>Although <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>CLCN2</i> pathogenic variants have been reported as a cause of <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> generalized epilepsies, including childhood absence epilepsy, juvenile myoclonic epilepsy, and epilepsy with grand mal seizures on awakening [<a class="bk_pop" href="#cc2-leuk.REF.haug.2003.527">Haug et al 2003</a>, <a class="bk_pop" href="#cc2-leuk.REF.d_agostino.2004.1500">D&#x02019;Agostino et al 2004</a>, <a class="bk_pop" href="#cc2-leuk.REF.stogmann.2006.265">Stogmann et al 2006</a>, <a class="bk_pop" href="#cc2-leuk.REF.everett.2007.145">Everett et al 2007</a>, <a class="bk_pop" href="#cc2-leuk.REF.combi.2009.89">Combi et al 2009</a>, <a class="bk_pop" href="#cc2-leuk.REF.kleefusslie.2009.954">Kleefuss-Lie at al 2009</a>, <a class="bk_pop" href="#cc2-leuk.REF.saintmartin.2009.397">Saint-Martin et al 2009</a>, <a class="bk_pop" href="#cc2-leuk.REF.klassen.2011.1036">Klassen et al 2011</a>], these findings remain controversial. The original paper supporting these results was retracted [<a class="bk_pop" href="#cc2-leuk.REF.haug.2009.1043">Haug et al 2009</a>]; although the authors still believed that mutation of <i>CLCN2</i> may contribute to epilepsy in some cases [<a class="bk_pop" href="#cc2-leuk.REF.haug.2009.1043">Haug et al 2009</a>, <a class="bk_pop" href="#cc2-leuk.REF.kleefusslie.2009.954">Kleefuss-Lie at al 2009</a>], functional studies of the <i>CLCN2</i> variants identified in individuals with epilepsy did not confirm their pathogenicity. Furthermore, similar variants were observed in individuals who did not have epilepsy [<a class="bk_pop" href="#cc2-leuk.REF.planellscases.2009.173">Planells-Cases &#x00026; Jentsch 2009</a>, <a class="bk_pop" href="#cc2-leuk.REF.niemeyer.2010.3">Niemeyer at al 2010</a>].</p><p>The observations in chloride channel-2 related leukoencephalopathy do not support the hypothesis that <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> <i>CLCN2</i> pathogenic variants confer an increased risk of epilepsy: No <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> (<a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a>) <i>CLCN2</i> pathogenic variants had epilepsy or a family history of epilepsy, indicating that partial or complete loss of chloride channel-2 function is insufficient per se to cause epilepsy.</p></div><div id="cc2-leuk.Differential_Diagnosis"><h2 id="_cc2-leuk_Differential_Diagnosis_">Differential Diagnosis</h2><p>Because the clinical findings of <i>CLCN2</i>-related leukoencephalopathy (CC2L) are nonspecific, it is not possible to establish the diagnosis on a clinical basis alone or to develop a differential diagnosis.</p><p>In contrast, the differential diagnosis of the MRI findings of bilateral symmetric signal abnormalities of the middle cerebellar peduncles and variable signal abnormalities in the brain stem and cerebellar and cerebral white matter include the following:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/lad-ad/">Adult autosomal dominant leukoencephalopathy related to <i>LMNB1</i> duplications</a> is characterized by executive dysfunction, memory decline, personality changes, motor impairments, and seizures. Mean age of onset is in the fourth decade. Affected individuals eventually become bedridden with spasticity and rigidity. Brain MRI is characterized by cerebral white matter abnormalities with frontal preponderance.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/fragilex/">Fragile X-associated tremor/ataxia syndrome</a>, which occurs in adult males (and some females) who have an <i>FMR1</i> <a class="def" href="/books/n/gene/glossary/def-item/premutation/">premutation</a>, is characterized by late-adult onset progressive cerebellar ataxia and intention tremor. Brain MRI shares with CC2L the typical middle cerebellar peduncle signal abnormalities, but lacks both the signal abnormalities in the cerebral peduncles and posterior limbs of the internal capsules and the diffusion restriction typical of CC2L.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/wilson/">Wilson disease</a> is a disorder of copper metabolism that can present with hepatic, neurologic, or psychiatric disturbances, or a combination of these, in individuals ranging from age three years to older than 50 years. Kayser-Fleischer rings resulting from copper deposition in Descemet&#x02019;s membrane of the cornea are frequently present. Abnormalities of brain MRI are highly variable and may involve the brain stem, but with a configuration different from that of CC2L.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/alexander/">Adult-onset Alexander disease</a> mainly affects the lower brain stem, which is clinically evident as bulbar dysfunction. The hallmark brain MRI abnormality is atrophy of the medulla oblongata. Brain stem signal abnormalities with a predilection for the medulla may also be present.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/x-ald/">Adrenomyeloneuropathy</a> manifests most commonly in the late twenties with progressive paraparesis, sphincter disturbances, sexual dysfunction, and often impaired adrenocortical function. All features are progressive over decades. The primary MRI finding is spinal cord atrophy. Corticopontine and corticospinal projection fibers are frequently involved.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/ctx/">Cerebrotendinous xanthomatosis</a> is characterized by infantile-onset diarrhea, childhood-onset cataract, adolescent- to young adult-onset tendon xanthomas, and adult-onset progressive neurologic dysfunction with dementia, psychiatric disturbances, pyramidal and/or cerebellar signs, dystonia, atypical parkinsonism, peripheral neuropathy, and seizures. The most important and earliest MRI abnormalities are signal abnormalities in the dentate nucleus and cerebellar hemispheric white matter. Additionally, signal abnormalities are often present in the corticospinal tracts and medial lemniscus in the brain stem, and slight signal changes are often seen in the periventricular cerebral white matter.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/lbsl/">Leukoencephalopathy with brain stem and spinal cord abnormalities and lactate elevation</a> (LBSL) is characterized by slowly progressive cerebellar ataxia and spasticity with dorsal column dysfunction. Deterioration of motor skills usually starts in childhood or adolescence, but occasionally not until adulthood. MRI invariably shows spinal cord signal abnormalities over its entire length. Brain stem signal abnormalities are more variable and rarely involve the middle cerebellar peduncles and cerebral peduncles.</div></li></ul><p>All disorders mentioned can be differentiated by the MRI findings mentioned and the diagnosis can be confirmed by appropriate biochemical and/or genetic testing.</p><p>See also <a href="/books/n/gene/leukodys-ov/">Leukodystrophy Overview</a>, which should cover all or most of the differential diagnosis information for this disorder.</p></div><div id="cc2-leuk.Management"><h2 id="_cc2-leuk_Management_">Management</h2><div id="cc2-leuk.Evaluations_Following_Initial_D"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>CLCN2</i>-related leukoencephalopathy (CC2L), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Neurologic examination</div></li><li class="half_rhythm"><div>Brain MRI if not performed at the time of diagnostic work up</div></li><li class="half_rhythm"><div>Physical therapy/occupational therapy assessment, if significant neurologic problems are present</div></li><li class="half_rhythm"><div>Ophthalmologic examination with attention to visual acuity and visual fields</div></li><li class="half_rhythm"><div>Audiologic examination</div></li><li class="half_rhythm"><div>For adult males: evaluation of testicular function</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="cc2-leuk.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Supportive therapy includes the following as needed:</p><ul><li class="half_rhythm"><div>Physical therapy and rehabilitation to improve motor function</div></li><li class="half_rhythm"><div>Special education</div></li><li class="half_rhythm"><div>Treatment of headache</div></li><li class="half_rhythm"><div>Guidance for visual impairment</div></li><li class="half_rhythm"><div>For males with infertility: consultation with a male infertility specialist</div></li></ul></div><div id="cc2-leuk.Surveillance"><h3>Surveillance</h3><p>Annual evaluations including:</p><ul><li class="half_rhythm"><div>Neurologic examination</div></li><li class="half_rhythm"><div>Ophthalmologic examination</div></li><li class="half_rhythm"><div>Audiologic assessment</div></li></ul><p>MRI follow up can be performed once every few years, in the event that the neurologic manifestations change.</p></div><div id="cc2-leuk.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Using the <i>CLCN2</i> pathogenic variants identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, it is appropriate to evaluate the older and younger sibs of a proband in order to identify those who would benefit from early diagnosis and routine surveillance for motor, cognitive, vision, and hearing impairment.</p><p>See <a href="#cc2-leuk.Related_Genetic_Counseling_Issu">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cc2-leuk.Pregnancy_Management"><h3>Pregnancy Management</h3><p>No pregnancy complications have been identified in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> women to date [Author, personal observation].</p></div><div id="cc2-leuk.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="cc2-leuk.Genetic_Counseling"><h2 id="_cc2-leuk_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cc2-leuk.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>CLCN2</i>-related leukoencephalopathy (CC2L) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="cc2-leuk.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>CLCN2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Offspring will inherit a <i>CLCN2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from a parent with CC2L.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>CLCN2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="cc2-leuk.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>CLCN2</i> pathogenic variants in the family.</p></div><div id="cc2-leuk.Related_Genetic_Counseling_Issu"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#cc2-leuk.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cc2-leuk.Prenatal_Testing_and_Preimplant"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>CLCN2</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for CC2L are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="cc2-leuk.Resources"><h2 id="_cc2-leuk_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><p>No specific resources for <i>CLCN2</i>-Related Leukoencephalopathy have been identified by <i>GeneReviews</i> staff.</p></div><div id="cc2-leuk.Molecular_Genetics"><h2 id="_cc2-leuk_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cc2-leuk.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>CLCN2-Related Leukoencephalopathy: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK326661/table/cc2-leuk.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cc2-leuk.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cc2-leuk.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cc2-leuk.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cc2-leuk.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cc2-leuk.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cc2-leuk.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cc2-leuk.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cc2-leuk.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1181" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CLCN2</i></a></td><td headers="hd_b_cc2-leuk.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1181" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3q27<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_cc2-leuk.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P51788" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Chloride channel protein 2</a></td><td headers="hd_b_cc2-leuk.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/CLCN2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CLCN2 database</a></td><td headers="hd_b_cc2-leuk.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CLCN2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CLCN2</a></td><td headers="hd_b_cc2-leuk.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CLCN2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CLCN2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cc2-leuk.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cc2-leuk.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for CLCN2-Related Leukoencephalopathy (<a href="/omim/600570,615651" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK326661/table/cc2-leuk.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cc2-leuk.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600570" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600570</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHLORIDE CHANNEL 2; CLCN2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615651" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615651</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>CLCN2</i> comprises 15,467 base pairs. The longest transcript variant, <a href="/nuccore/NM_004366.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004366.5</a>, has 24 exons. The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> has been reported to encode ten transcript variants, four of which are protein-coding. For details on gene and transcripts, see <a href="/books/NBK326661/#cc2-leuk.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> To date 18 pathogenic variants have been identified in 15 probands.</p><p>Six variants are located in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 14 and two in exon 11; the remaining are distributed throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p><p>With the small number of known <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals to date, no information is available on prevalence in specific ethnic groups.</p><div id="cc2-leuk.T.clcn2_variants_known_to_the_a" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>CLCN2</i> Variants Known to the Authors</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK326661/table/cc2-leuk.T.clcn2_variants_known_to_the_a/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cc2-leuk.T.clcn2_variants_known_to_the_a_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant<br />Classification</th><th id="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference<br />Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_1" rowspan="20" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Uncertain</b><br /><b>significance&#x000a0;<sup>1</sup></b></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.130G&#x0003e;A&#x000a0;<sup>2</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly44Arg</td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_4" rowspan="39" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_004366.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004366<wbr style="display:inline-block"></wbr>​.5</a><br /><a href="/protein/NP_004357.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_004357<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.143C&#x0003e;G&#x000a0;<sup>3</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro48Arg&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.203G&#x0003e;A&#x000a0;<sup>3</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg68His&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.218G&#x0003e;A&#x000a0;<sup>2</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg73His</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.246C&#x0003e;G&#x000a0;<sup>2</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe82Leu</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">c.221-14_221-4del11&#x000a0;<sup>5</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.596G&#x0003e;C&#x000a0;<sup>3</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly199Ala&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.704G&#x0003e;A&#x000a0;<sup>6</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg235Gln&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1730G&#x0003e;A&#x000a0;<sup>6</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg577Gln&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1856&#x02013;3C&#x0003e;T&#x000a0;<sup>7</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.0?&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1930C&#x0003e;T&#x000a0;<sup>6</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg644Cys</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1937G&#x0003e;A&#x000a0;<sup>3</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg646Gln&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2003C&#x0003e;G&#x000a0;<sup>2</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr668Ser</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2063G&#x0003e;A&#x000a0;<sup>2,&#x000a0;7,&#x000a0;9</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg688Gly</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c. 2144G&#x0003e;A</td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly715Glu</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2154G&#x0003e;C&#x000a0;<sup>7,&#x000a0;9</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu718Asp</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2173C&#x0003e;T&#x000a0;<sup>3</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg725Trp&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2240G&#x0003e;A&#x000a0;<sup>3</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg747His&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2273G&#x0003e;A&#x000a0;<sup>2</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser758Asn</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2279C&#x0003e;T&#x000a0;<sup>2</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala760Val</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Possibly</b><br /><b>pathogenic</b></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.597dup&#x000a0;<sup>5</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met200AspfsTer32</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_1" rowspan="18" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pathogenic</b></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.64-1107_639del&#x000a0;<sup>10</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met22LeufsTer5</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.292G&#x0003e;C&#x000a0;<sup>11</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly98Arg&#x000a0;<sup>11</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.430_435del&#x000a0;<sup>10</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu144_Ile145del</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.828dupG&#x000a0;<sup>10</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg277AlafsTer23</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.925C&#x0003e;T&#x000a0;<sup>11</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg309Ter&#x000a0;<sup>11</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1015G&#x0003e;C&#x000a0;<sup>11</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val339Leu&#x000a0;<sup>11</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1113delinsACTGCTCAT&#x000a0;<sup>12</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser375CysfsTer6</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1143delT&#x000a0;<sup>10</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly382AlafsTer34</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1304delT&#x000a0;<sup>11</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu435ArgfsTer7&#x000a0;<sup>11</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1397G&#x0003e;A&#x000a0;<sup>11</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly466Glu&#x000a0;<sup>11</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1412G&#x0003e;A&#x000a0;<sup>11</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg471His&#x000a0;<sup>11</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1422_1423delTG&#x000a0;<sup>11</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu475LysfsTer79&#x000a0;<sup>11</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1499C&#x0003e;T&#x000a0;<sup>10</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala500Val</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1507G&#x0003e;A&#x000a0;<sup>13</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly503Arg</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1709G&#x0003e;A&#x000a0;<sup>2,&#x000a0;10</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp570Ter</td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1795G&#x0003e;A&#x000a0;<sup>11</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp599Asn&#x000a0;<sup>11</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1957A&#x0003e;T&#x000a0;<sup>11</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg653Ter&#x000a0;<sup>11</sup></td></tr><tr><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2386C&#x0003e;T&#x000a0;<sup>11</sup></td><td headers="hd_h_cc2-leuk.T.clcn2_variants_known_to_the_a_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln796Ter&#x000a0;<sup>11</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="cc2-leuk.TF.2.1"><p class="no_margin">Variants reported here were identified in the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state in patients with epilepsy and/or control individuals.</p></div></dd><dt>2. </dt><dd><div id="cc2-leuk.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#cc2-leuk.REF.klassen.2011.1036">Klassen et al [2011]</a></p></div></dd><dt>3. </dt><dd><div id="cc2-leuk.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#cc2-leuk.REF.paul.2007.441">Paul et al [2007]</a></p></div></dd><dt>4. </dt><dd><div id="cc2-leuk.TF.2.4"><p class="no_margin">These variants were shown to have a functional impact on CLC-2 function but the pathogenicity of these variants for CC2L in the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> state remains unproven.</p></div></dd><dt>5. </dt><dd><div id="cc2-leuk.TF.2.5"><p class="no_margin"><a class="bk_pop" href="#cc2-leuk.REF.haug.2003.527">Haug et al [2003]</a></p></div></dd><dt>6. </dt><dd><div id="cc2-leuk.TF.2.6"><p class="no_margin"><a class="bk_pop" href="#cc2-leuk.REF.saintmartin.2009.397">Saint-Martin et al [2009]</a></p></div></dd><dt>7. </dt><dd><div id="cc2-leuk.TF.2.7"><p class="no_margin"><a class="bk_pop" href="#cc2-leuk.REF.d_agostino.2004.1500">D&#x02019;Agostino et al [2004]</a></p></div></dd><dt>8. </dt><dd><div id="cc2-leuk.TF.2.8"><p class="no_margin">Effect on protein unknown</p></div></dd><dt>9. </dt><dd><div id="cc2-leuk.TF.2.9"><p class="no_margin"><a class="bk_pop" href="#cc2-leuk.REF.stogmann.2006.265">Stogmann et al [2006]</a></p></div></dd><dt>10. </dt><dd><div id="cc2-leuk.TF.2.10"><p class="no_margin"><a class="bk_pop" href="#cc2-leuk.REF.depienne.2013.659">Depienne et al [2013]</a></p></div></dd><dt>11. </dt><dd><div id="cc2-leuk.TF.2.11"><p class="no_margin">Author, unpublished data</p></div></dd><dt>12. </dt><dd><div id="cc2-leuk.TF.2.12"><p class="no_margin"><a class="bk_pop" href="#cc2-leuk.REF.hanagasi.2015.544">Hanagasi et al [2015]</a></p></div></dd><dt>13. </dt><dd><div id="cc2-leuk.TF.2.13"><p class="no_margin"><a class="bk_pop" href="#cc2-leuk.REF.di_bella.2014.1217">Di Bella et al [2014]</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The start of the <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 is utilized in all four transcript variants. The longest protein-coding transcript <a href="/nuccore/NM_004366.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004366.5</a> expresses a protein encompassing 898 amino acids. This protein has 12 transmembrane domains and two intracellular CBS domains, and constitutes a voltage-gated chloride channel present at the plasma membrane.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> All pathogenic variants identi&#x0fb01;ed to date have been shown or suggested to result in either complete or partial loss of function of the protein chloride channel-2 by different mechanisms [<a class="bk_pop" href="#cc2-leuk.REF.depienne.2013.659">Depienne at al 2013</a>]. Overexpression studies have shown that the proteins with the variant p.Leu144_Ile145del, p.Ala500Val, or p.Trp570Ter are retained in the endoplasmic reticulum and are not transported to the plasma membrane. Pathogenic variants introducing a premature termination codon probably lead to <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> degradation by <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>-mediated decay [<a class="bk_pop" href="#cc2-leuk.REF.depienne.2013.659">Depienne et al 2013</a>]. Not all variants have, however, been tested [<a class="bk_pop" href="#cc2-leuk.REF.di_bella.2014.1217">Di Bella et al 2014</a>; <a class="figpopup" href="/books/NBK326661/table/cc2-leuk.T.clcn2_variants_known_to_the_a/?report=objectonly" target="object" rid-figpopup="figcc2leukTclcn2variantsknowntothea" rid-ob="figobcc2leukTclcn2variantsknowntothea">Table 2</a>, footnote 11].</p><p><b>Mouse model.</b>
<i>Clcn2</i>-mutant and knockout mice have been studied since 2001 [<a class="bk_pop" href="#cc2-leuk.REF.b_sl.2001.1289">B&#x000f6;sl et al 2001</a>, <a class="bk_pop" href="#cc2-leuk.REF.blanz.2007.6581">Blanz et al 2007</a>, <a class="bk_pop" href="#cc2-leuk.REF.edwards.2010.3264">Edwards et al 2010</a>]. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is dominated by visual impairment due to retinopathy and male infertility due to testicular degeneration resulting in azoospermia. A leukoencephalopathy characterized by intramyelinic edema was observed when investigating the brain, but was not clinically apparent [<a class="bk_pop" href="#cc2-leuk.REF.blanz.2007.6581">Blanz et al 2007</a>, <a class="bk_pop" href="#cc2-leuk.REF.edwards.2010.3264">Edwards et al 2010</a>]. The mutated mice had no other disease signs and had a normal life span [<a class="bk_pop" href="#cc2-leuk.REF.b_sl.2001.1289">B&#x000f6;sl et al 2001</a>, <a class="bk_pop" href="#cc2-leuk.REF.blanz.2007.6581">Blanz et al 2007</a>, <a class="bk_pop" href="#cc2-leuk.REF.edwards.2010.3264">Edwards et al 2010</a>].</p></div><div id="cc2-leuk.References"><h2 id="_cc2-leuk_References_">References</h2><div id="cc2-leuk.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.blanz.2007.6581">Blanz J, Schweizer M, Auberson M, Maier H, Muenscher A, H&#x000fc;bner CA, Jentsch TJ. Leukoencephalopathy upon disruption of the chloride channel ClC-2. <span><span class="ref-journal">J Neurosci. </span>2007;<span class="ref-vol">27</span>:6581–9.</span> [<a href="/pmc/articles/PMC6672451/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6672451</span></a>] [<a href="/pubmed/17567819" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17567819</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.b_sl.2001.1289">B&#x000f6;sl MR, Stein V, H&#x000fc;bner C, Zdebik AA, Jordt SE, Mukhopadhyay AK, Davidoff MS, Holstein AF, Jentsch TJ. Male germ cells and photoreceptors, both dependent on close cell-cell interactions, degenerate upon ClC-2 Cl(-) channel disruption. <span><span class="ref-journal">EMBO J. </span>2001;<span class="ref-vol">20</span>:1289–99.</span> [<a href="/pmc/articles/PMC145530/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC145530</span></a>] [<a href="/pubmed/11250895" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11250895</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.combi.2009.89">Combi R, Grioni D, Contri M, Redaelli S, Redaelli F, Bassi MT, Barisani D, Lavitrano ML, Tredici G, Tenchini ML, Bertolini M, Dalpr&#x000e0; L. Clinical and genetic familial study of a large cohort of Italian children with idiopathic epilepsy. <span><span class="ref-journal">Brain Res Bull. </span>2009;<span class="ref-vol">79</span>:89–96.</span> [<a href="/pubmed/19200853" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19200853</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.d_agostino.2004.1500">D&#x02019;Agostino D, Bertelli M, Gallo S, Cecchin S, Albiero E, Garofalo PG, Gambardella A, St Hilaire JM, Kwiecinski H, Andermann E, Pandolfo M. Mutations and polymorphisms of the CLCN2 gene in idiopathic epilepsy. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">63</span>:1500–2.</span> [<a href="/pubmed/15505175" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15505175</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.depienne.2013.659">Depienne C, Bugiani M, Dupuits C, Galanaud D, Touitou V, Postma N, van Berkel C, Polder E, Tollard E, Darios F, Brice A, de Die-Smulders CE, Vles JS, Vanderver A, Uziel G, Yalcinkaya C, Frints SG, Kalscheuer VM, Klooster J, Kamermans M, Abbink TE, Wolf NI, Sedel F, van der Knaap MS. Brain white matter oedema due to ClC-2 chloride channel deficiency: an observational analytical study. <span><span class="ref-journal">Lancet Neurol. </span>2013;<span class="ref-vol">12</span>:659–68.</span> [<a href="/pubmed/23707145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23707145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.di_bella.2014.1217">Di Bella D, Pareyson D, Savoiardo M, Farina L, Ciano C, Caldarazzo S, Sagnelli A, Bonato S, Nava S, Bresolin N, Tedeschi G, Taroni F, Salsano E. Subclinical leukodystrophy and infertility in a man with a novel homozygous CLCN2 mutation. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">83</span>:1217–8.</span> [<a href="/pubmed/25128180" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25128180</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.edwards.2010.3264">Edwards MM, Marin de Evsikova C, Collin GB, Gifford E, Wu J, Hicks WL, Whiting C, Varvel NH, Maphis N, Lamb BT, Naggert JK, Nishina PM, Peachey NS. Photoreceptor degeneration, azoospermia, leukoencephalopathy, and abnormal RPE cell function in mice expressing an early stop mutation in CLCN2. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2010;<span class="ref-vol">51</span>:3264–72.</span> [<a href="/pmc/articles/PMC2891478/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2891478</span></a>] [<a href="/pubmed/20071672" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20071672</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.everett.2007.145">Everett K, Chioza B, Aicardi J, Aschauer H, Brouwer O, Callenbach P, Covanis A, Dooley J, Dulac O, Durner M, Eeg-Olofsson O, Feucht M, Friis M, Guerrini R, Heils A, Kjeldsen M, Nabbout R, Sander T, Wirrell E, McKeigue P, Robinson R, Taske N, Gardiner M. Linkage and mutational analysis of CLCN2 in childhood absence epilepsy. <span><span class="ref-journal">Epilepsy Res. </span>2007;<span class="ref-vol">75</span>:145–53.</span> [<a href="/pubmed/17580110" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17580110</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.hanagasi.2015.544">Hanagasi HA, Bilgi&#x000e7; B, Abbink TE, Hanagasi F, T&#x000fc;fek&#x000e7;io&#x0011f;lu Z, G&#x000fc;rvit H, Ba&#x0015f;ak N, van der Knaap MS, Emre M. Secondary paroxysmal kinesigenic dyskinesia associated with CLCN2 gene mutation. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2015;<span class="ref-vol">21</span>:544–6.</span> [<a href="/pubmed/25745790" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25745790</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.haug.2003.527">Haug K, Warnstedt M, Alekov AK, Sander T, Ram&#x000ed;rez A, Poser B, Maljevic S, Hebeisen S, Kubisch C, Rebstock J, Horvath S, Hallmann K, Dullinger JS, Rau B, Haverkamp F, Beyenburg S, Schulz H, Janz D, Giese B, M&#x000fc;ller-Newen G, Propping P, Elger CE, Fahlke C, Lerche H, Heils A. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">33</span>:527–32.</span> [<a href="/pubmed/12612585" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12612585</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.haug.2009.1043">Haug K, Warnstedt M, Alekov AK, Sander T, Ram&#x000ed;rez A, Poser B, Maljevic S, Hebeisen S, Kubisch C, Rebstock J, Horvath S, Hallmann K, Dullinger JS, Rau B, Haverkamp F, Beyenburg S, Schulz H, Janz D, Giese B, M&#x000fc;ller-Newen G, Propping P, Elger CE, Fahlke C, Lerche H. Retraction: Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:1043.</span> [<a href="/pubmed/19710717" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19710717</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.klassen.2011.1036">Klassen T, Davis C, Goldman A, Burgess D, Chen T, Wheeler D, McPherson J, Bourquin T, Lewis L, Villasana D, Morgan M, Muzny D, Gibbs R, Noebels J. Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy. <span><span class="ref-journal">Cell. </span>2011;<span class="ref-vol">145</span>:1036–48.</span> [<a href="/pmc/articles/PMC3131217/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3131217</span></a>] [<a href="/pubmed/21703448" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21703448</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.kleefusslie.2009.954">Kleefuss-Lie A, Friedl W, Cichon S, Haug K, Warnstedt M, Alekov A, Sander T, Ramirez A, Poser B, Maljevic S, Hebeisen S, Kubisch C, Rebstock J, Horvath S, Hallmann K, Dullinger JS, Rau B, Haverkamp F, Beyenburg S, Schulz H, Janz D, Giese B, M&#x000fc;ller-Newen G, Propping P, Elger CE, Fahlke C, Lerche H. CLCN2 variants in idiopathic generalized epilepsy. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:954–5.</span> [<a href="/pubmed/19710712" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19710712</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.niemeyer.2010.3">Niemeyer MI, Cid LP, Sep&#x000fa;lveda FV, Blanz J, Auberson M, Jentsch TJ. No evidence for a role of CLCN2 variants in idiopathic generalized epilepsy. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:3.</span> [<a href="/pubmed/20037607" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20037607</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.paul.2007.441">Paul J, Jeyaraj S, Huber SM, Seebohm G, B&#x000f6;hmer C, Lang F, Kremsner PG, Kun JF. Alterations in the cytoplasmic domain of CLCN2 result in altered gating kinetics. <span><span class="ref-journal">Cell Physiol Biochem. </span>2007;<span class="ref-vol">20</span>:441–54.</span> [<a href="/pubmed/17762171" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17762171</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.planellscases.2009.173">Planells-Cases R, Jentsch TJ. Chloride channelopathies. <span><span class="ref-journal">Biochim Biophys Acta. </span>2009;<span class="ref-vol">1792</span>:173–89.</span> [<a href="/pubmed/19708126" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19708126</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.saintmartin.2009.397">Saint-Martin C, Gauvain G, Teodorescu G, Gourfinkel-An I, Fedirko E, Weber YG, Maljevic S, Ernst JP, Garcia-Olivares J, Fahlke C, Nabbout R, LeGuern E, Lerche H, Poncer JC, Depienne C. Two novel CLCN2 mutations accelerating chloride channel deactivation are associated with idiopathic generalized epilepsy. <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:397–405.</span> [<a href="/pubmed/19191339" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19191339</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.schiffmann.2009.750">Schiffmann R, van der Knaap MS. Invited article: an MRI-based approach to the diagnosis of white matter disorders. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">72</span>:750–9.</span> [<a href="/pmc/articles/PMC2677542/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2677542</span></a>] [<a href="/pubmed/19237705" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19237705</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cc2-leuk.REF.stogmann.2006.265">Stogmann E, Lichtner P, Baumgartner C, Schmied M, Hotzy C, Asmus F, Leutmezer F, Bonelli S, Assem-Hilger E, Vass K, Hatala K, Strom TM, Meitinger T, Zimprich F, Zimprich A. Mutations in the <em>CLCN2</em> gene are a rare cause of idiopathic generalized epilepsy syndromes. <span><span class="ref-journal">Neurogenetics. </span>2006;<span class="ref-vol">7</span>:265–8.</span> [<a href="/pubmed/16932951" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16932951</span></a>]</div></li></ul></div></div><div id="cc2-leuk.Chapter_Notes"><h2 id="_cc2-leuk_Chapter_Notes_">Chapter Notes</h2><div id="cc2-leuk.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>5 November 2015 (me) Review posted live</div></li><li class="half_rhythm"><div>22 April 2015 (mvdk) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK326661</span><span class="label">PMID: <a href="/pubmed/26539602" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">26539602</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cd-chst3/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/clcn7/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK326661&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK326661/?report=reader">PubReader</a></li><li><a href="/books/NBK326661/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK326661" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK326661" style="display:none" title="Cite this Page"><div class="bk_tt">van der Knaap MS, Depienne C, Sedel F, et al. CLCN2-Related Leukoencephalopathy. 2015 Nov 5. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK326661/pdf/Bookshelf_NBK326661.pdf">PDF version of this page</a> (793K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cc2-leuk.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cc2-leuk.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cc2-leuk.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cc2-leuk.Genetically_Related_Allelic_Dis" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#cc2-leuk.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cc2-leuk.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cc2-leuk.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cc2-leuk.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cc2-leuk.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cc2-leuk.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cc2-leuk.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1181[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CLCN2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4135690" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4135690" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4135690" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4135690" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27891836" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> CLPB Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> CLPB Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wortmann SB, Wevers RA, de Brouwer APM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25254289" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Perrault Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Perrault Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Newman WG, Friedman TB, Conway GS, Demain LAM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29276893" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pelizaeus-Merzbacher-Like Disease 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pelizaeus-Merzbacher-Like Disease 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nahhas N, Conant A, Orthmann-Murphy J, Vanderver A, Hobson G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301468" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sparks SE, Quijano-Roy S, Harper A, Rutkowski A, Gordon E, Hoffman EP, Pegoraro E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301570" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alpha-Mannosidosis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Alpha-Mannosidosis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Malm D, Nilssen Ø. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=26539602" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=26539602" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040ebadd21425a25707413">CLCN2-Related Leukoencephalopathy - GeneReviews®</a><div class="ralinkpop offscreen_noflow">CLCN2-Related Leukoencephalopathy - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:36:59-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D2FC2E03F856100000000084D02CD&amp;ncbi_session=CE8D2FC2E040EBA1_2125SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK326661%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK326661&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK326661/&amp;ncbi_pagename=CLCN2-Related Leukoencephalopathy - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D2FC2E040EBA1_2125SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>